StammeringNCT06937437
Effects of Tele Speech Therapy on the Treatment of Stammering in Adults Who Stutter
A study testing Teletherapy and Traditionally speech therapy in people with Stammering, run by Riphah International University at 1 site in Pakistan.
Trial summary
The aim of the study is to determine the effectiveness of telespeech therapy on the treatment of stammering. Read more about this study
- Who is it for?
- Ages 15 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- Stammering
- What is being tested?
- Teletherapy and Traditionally speech therapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 16 participants
- Where
- 1 sitePakistan
- Study dates
- 20 Mar 2025to 29 Jun 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 40 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Both Genders
- Adults With stuttering 15 to 40 years according to WHO criteria
Who cannot join
- Stammering with any comorbid are excluded eg. Visual and Hearing Impairment
Trial locations and contacts
1 site in 1 country.
About this study
The aim of the study is to determine the effectiveness of telespeech therapy on the treatment of stammering.
- Conditions
- Stammering
- Being tested
- Teletherapy, Traditionally speech therapy
- Medical subject headings
- Stuttering
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TeletherapyOther
A teletherapy patient presenting with stammering (stuttering) is a person receiving speech therapy remotely, using technology like video conferencing, to address speech fluency difficulties, often including repetitions, prolongations, or blocks in speech.
Traditionally speech therapyOther
This type of intervention is traditional speech therapy that will be given to stammering adults, to address speech fluency difficulties, often including repetitions, prolongations, or blocks in speech.
| Study group | Role | What they receive |
|---|---|---|
| Tele therapy | Experimental | The experimental group will be given teletherapy, total number of 2 sessions per week, each participant comprising 30 minutes. Receives: Other: Teletherapy |
| Traditionally speech therapy | Active comparator | Traditional therapy will be given a total of 2 sessions per week to each participant, comprised of 30 minutes Receives: Other: Traditionally speech therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Stuttering Severity Instrument - Fourth Edition (SSI4)
The Stuttering Severity Instrument-Fourth Edition (SSI-4) is a norm-referenced assessment used to quantify stuttering severity in children and adults, measuring frequency, duration, physical concomitants, and the naturalness of speech.
The total score measures the overall severity of the individual's stuttering disorder. The examiner adds scores from the frequency, duration, and physical concomitants sections to obtain the severity score and percentile rank. These are calculated using the tables within the record form. These tables also convert scores to a severity equivalent, which ranges from "very mild" to "very severe".
It has a total score range of 0 to 20 for physical concomitants, and 2 to 18 for frequency and duration. The total score for the entire instrument is the sum of these three scores, making the overall range up to 20 + 18 + 18 = 56.
Measured: Base line and 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Apr 2025
- Study start20 Mar 2025
- Primary completion20 Jun 2025
- Study completion29 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for StammeringStudies of the same condition, open and under way.
- More trials run by Riphah International UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 16 participants (actual)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Mamona Riaz, M.S, Principal investigator, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06937437
- Sponsor's protocol ID
- REC/RCR&AHS/24/0664
- Status last verified
- Jul 2025
- First submitted
- 7 Apr 2025
- Last updated
- 15 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Månsson H. Childhood stuttering: Incidence and development. Journal of fluency disorders. 2000;25(1):47-57.
Eslami Jahromi M, Ahmadian L, Bahaadinbeigy K. The effect of tele-speech therapy on treatment of stuttering. Disabil Rehabil Assist Technol. 2022 Jan;17(1):34-39. doi: 10.1080/17483107.2020.1754475. Epub 2020 Apr 17.
PubMed 32299263
Study at a glance
From the registry record, last updated by the sponsor on 15 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Tele Speech Therapy on the Treatment of Stammering in Adults Who Stutter
- ClinicalTrials.gov ID
- NCT06937437
- Acronym / sponsor ID
- REC/RCR&AHS/24/0664
- Conditions
- Stammering
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 16 participants (actual)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 20 Mar 2025 (actual)
- Primary completion
- 20 Jun 2025 (actual)
- Study completion
- 29 Jun 2025 (actual)
- First posted
- 22 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study is to determine the effectiveness of telespeech therapy on the treatment of stammering.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Tele therapy | Experimental | Other: TeletherapyThe experimental group will be given teletherapy, total number of 2 sessions per week, each participant comprising 30 minutes. |
| Traditionally speech therapy | Active comparator | Other: Traditionally speech therapyTraditional therapy will be given a total of 2 sessions per week to each participant, comprised of 30 minutes |
Who may qualify
- Ages
- 15 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (2 listed)
- Both Genders
- Adults With stuttering 15 to 40 years according to WHO criteria
Key exclusion criteria (1 listed)
- Stammering with any comorbid are excluded eg. Visual and Hearing Impairment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TeletherapyA teletherapy patient presenting with stammering (stuttering) is a person receiving speech therapy remotely, using technology like video conferencing, to address speech fluency difficulties, often including repetitions, prolongations, or blocks in speech. | Other | Tele therapy |
| Traditionally speech therapyThis type of intervention is traditional speech therapy that will be given to stammering adults, to address speech fluency difficulties, often including repetitions, prolongations, or blocks in speech. | Other | Traditionally speech therapy |
Primary outcome
Stuttering Severity Instrument - Fourth Edition (SSI4)
Time frame: Base line and 6 weeks
The Stuttering Severity Instrument-Fourth Edition (SSI-4) is a norm-referenced assessment used to quantify stuttering severity in children and adults, measuring frequency, duration, physical concomitants, and the naturalness of speech. The total score measures the overall severity of the individual's stuttering disorder. The examiner adds scores from the frequency, duration, and physical concomitants sections to obtain the severity score and percentile rank. These are calculated using the tables within the record form. These tables also convert scores to a severity equivalent, which ranges from "very mild" to "very severe". It has a total score range of 0 to 20 for physical concomitants, and 2 to 18 for frequency and duration. The total score for the entire instrument is the sum of these three scores, making the overall range up to 20 + 18 + 18 = 56.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jul 2025.
- BackgroundMånsson H. Childhood stuttering: Incidence and development. Journal of fluency disorders. 2000;25(1):47-57.
- Background: PubMed 32299263Eslami Jahromi M, Ahmadian L, Bahaadinbeigy K. The effect of tele-speech therapy on treatment of stuttering. Disabil Rehabil Assist Technol. 2022 Jan;17(1):34-39. doi: 10.1080/17483107.2020.1754475. Epub 2020 Apr 17.
- Individual participant dataSharing planned: No
Related trials for Stammering
Not yet recruiting
Effectiveness of Virtually Simulated Intervention for Patients Having Stuttering
Stuttering
Recruiting
Using Non-invasive Brain Stimulation to Explore Potential Treatments to Reduce Speech Errors in Adults Who Stutter
Stuttering, Fluency Disorder
Recruiting
Network Connectivity and Temporal Processing in Adolescents Who Stutter
Stuttering, Childhood, Stuttering
Recruiting
Transcranial Alternating Current Stimulation (tACS) in Stuttering
Stuttering, Adult, Stuttering, Childhood
Not yet recruiting
Development and Pilot Testing of Virtually Simulated Intervention for Patients Having Stuttering
Stuttering
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mamona Riaz, M.S principal investigator
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Teletherapy and Traditionally speech therapy in people with Stammering, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Stuttering Severity Instrument - Fourth Edition (SSI4) (time frame: Base line and 6 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06937437, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2025.